Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0050 (-4.76%)
Jan 20, 2026, 3:11 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 11.43 million as of January 20, 2026. Its market cap has decreased by -59.03% in one year.
Market Cap
11.43M
Enterprise Value
10.53M
Revenue
754.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 11.43M, an increase of 72.19%. That is a compound annual growth rate of 14.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 11.43M | -4.55% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 18.86M |
| PreveCeutical Medical | 14.95M |
| Innovotech | 13.52M |
| Britannia Life Sciences | 12.98M |
| Cytophage Technologies | 12.18M |
| BioVaxys Technology | 10.58M |
| Glow Lifetech | 9.98M |
| COSCIENS Biopharma | 9.36M |